FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology, namely to using lithium ascorbate as a radiosensitizer. Agent represents lithium ascorbate with formula LiC6H7O6.
EFFECT: wider range of products having radiation-sensitizing activity.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING THE TRILITHIUM SALT OF PHOSPHO-ASCORBIC ACID | 2020 |
|
RU2752829C1 |
| MEANS WITH RADIO SENSITIZING EFFECT | 2021 |
|
RU2763884C1 |
| RADIOPROTECTIVE AGENT | 2020 |
|
RU2737898C1 |
| APOPTOSIS-INDUCING AGENTS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2709498C1 |
| METHOD OF THERAPY FOR COLORECTAL CANCER IN IN VIVO EXPERIMENT | 2023 |
|
RU2814946C1 |
| SENSITIZER FOR PHOTODYNAMIC DESTRUCTION OF TUMOR CELLS | 2021 |
|
RU2771237C1 |
| METHOD FOR ANIMAL TISSUE RADIOSENSIBILITY ENHANCEMENT | 2011 |
|
RU2498799C2 |
| METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
| AGENT OF APOPTOSIS-INDUCTIVE ACTIVITY | 2017 |
|
RU2654711C1 |
| RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
